“Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial (LIBERTY AD ADOL)”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s51. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1009.